Phase III COBRE: Multimodal Imaging of Neuropsychiatric Disorders (MIND)

$1,329,407P30FY2020GMNIH

Lovelace Biomedical Research Institute, Albuquerque NM

Investigators

Andrew Robert Mayercontact

Linked publications, trials & patents

Paper 39163909 Paper 39113416 Paper 38979810 Paper 38817039 Paper 38726907 Paper 38578669 Paper 38479461 Paper 38041476 Paper 38016527 Paper 37953849 Paper 37800467 Paper 37792293 Paper 37725586 Paper 37724718 Paper 37594499 Paper 37593449 Paper 37157056 Paper 36925066 Paper 36857850 Paper 36825526 Paper 36522161 Paper 36511519 Paper 36355185 Paper 35727944 Paper 35709557 Paper 35390278 Paper 35388581 Paper 35377682 Paper 35053856 Paper 34666262 Paper 34419765 Paper 34376268 Paper 34371285 Paper 34334188 Paper 34119500 Paper 33875230 Paper 33391043 Paper 33208189 Paper 33039623 Paper 32715898 Paper 32424299 Paper 32353485 Paper 32350978 Paper 32348350 Paper 32336400 Paper 32289703 Paper 32275915 Paper 32272117 Paper 32207187 Paper 32066697 Paper 32051642 Paper 31978489 Paper 31944934 Paper 31904902 Paper 31848068 Paper 31825974 Paper 31751666 Paper 31735637 Paper 31692997 Paper 31507357 Paper 31473543 Paper 31364696 Paper 31278651 Paper 31210734 Paper 31001569 Paper 30819594 Paper 30507492 Paper 30300752 Paper 30184473 Paper 30055372 Paper 29907493 Paper 29464530 Paper 28678703 Trial NCT04770025

View original record on NIH RePORTER →